Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential …

Imec is a world-leading R&D and innovation hub in nanoelectronics and digital technologies. At imec, we shape the future. How? By enabling nano- and digital technology innovation with a significant impact on the quality of life. With our partners from companies, governments and academia. And supported by the three pillars of our R&D: - a unique infrastructure that includes a 2.5-billion-euro 300mm semiconductor pilot line - more than 5,000 expert scientists from over 96 countries - an ecosystem of more than 600 world-leading industry partners and a global academic network Founded in 1984, imec quickly made its name as the …

We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them.

Sectors: Pharmaceutical

Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using …

Sectors: Biotechnology Pharmaceutical